ROSWELL PARK CANCER INST has a total of 13 patent applications. Its first patent ever was published in 1990. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are YEUNG ALEX WAH HIN, INST OF BASIC MEDICINE CHINESE and STRATHMANN AG & CO.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | United States | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | United Kingdom | 1 | |
#7 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Chenchik Alex | 4 |
#2 | Gudkov Andrei | 4 |
#3 | Kurenova Elena V | 4 |
#4 | Cance William G | 4 |
#5 | Komarov Andrei | 4 |
#6 | Johnson Candace S | 3 |
#7 | Trump Donald L | 3 |
#8 | Golubovskaya Vita | 2 |
#9 | Natarajan Venkatesh | 2 |
#10 | Pandey Ravindra K | 2 |
Publication | Filing date | Title |
---|---|---|
WO2013074517A1 | Kinase protein binding inhibitors | |
WO2012139001A2 | Kinase protein binding inhibitors | |
US2010305002A1 | Reagents and Methods for Producing Bioactive Secreted Peptides | |
AU2005228447A1 | Method of treating solid tumors and leukemias using combination therapy of vitamin D and anti-metabolic nucleoside analogs | |
GB9020558D0 | A bioassay for screening for inhibitors of the hiv proteinase |